AXS25 DigitalGuide V2 04.18 pages - Flipbook - Page 12
MONDAY, APRIL 28
2:00 PM - 2:40 PM
Margaux 1
Commercialization Considerations for Orphan/Rare, Cell & Gene, and
Precision Medicine
Brett Casper, Blue Fin Group
2:00 PM - 2:40 PM
Margaux 2
Specialty Pharmacy Access in the Community
Kevin Barton, Walmart; Kassem Elhelou, Walmart; Lisa Thornton, Walmart;
Rod Thornton, Johnson & Johnson
2:00 PM - 2:40 PM
Mouton 1
The Business Imperative: Addressing Healthcare Inequities for
Sustainable Growth and Strategies to Prioritize Business Growth
and Innovation
Melissa Paige, National Association of Medication Access & Patient Advocacy
(NAMAPA); Chara Reid, Cencora; Christie Smith, Cencora
2:00 PM - 2:40 PM
Mouton 2
How the Next 90 Days May Shape the Future of Managed Medicare
Andy Cournoyer, Precision AQ; Lance Grady, Precision AQ; Charline Shan, Precision
AQ; Jennifer Williams, Precision AQ
3:00 PM - 3:40 PM
Lafite 2
Beyond AI: What Other Technologies Will Affect Pharmacy?
George Van Antwerp, Prime Therapeutics; Chris Gilmore, Aprecia Pharmaceuticals;
Dan Knecht, Emblem Health; Jessica Zeaske, Echo Health Ventures
3:00 PM - 5:00 PM
Latour 2
CE: Transforming Metabolic Dysfunction-Associated Steatohepatitis
Management: Pharmacist Considerations for the Evolving
Treatment Landscape
Naim Alkhouri, Arizona Liver Health;
Dovena Lazaridis, Ambulatory and Population Health
3:00 PM - 5:00 PM
Latour 3
CE: Advancing Care in Neovascular Age-Related Macular
Degeneration and Diabetic Macular Edema: Optimizing Outcomes With
Emerging Therapies
Casey Koch, SelectHealth
3:00 PM - 3:40 PM
Margaux 1
Transforming Client Partnerships: A Case Study and Benchmarking
Readout on Enhancing Patient Outcomes and Success
Dee Chaudhary, Clarivate Commercial Strategy Consulting;
Meghan Hover, SK Life Sciences; Paul Battaglia, Two Labs Pharma Services
* as of March 29, 2025
12 I DIGITAL GUIDE
